App-Quantinova.ai

Vasoconstriction During Mental Stress Predicts Severity of Mental Stress Induced Myocardial Ischemia

Ayman AlKhoder - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

sestamibi

New Insights into the Mechanisms of Sepsis: The Role of Proprotein Convertase Subtilisin/kexin Type 9 as a Key Regulator of Pathogen Toxin Clearance

Yingjin Wang - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Sepsis

N/A

Is the Post-menopausal Rise in PCSK9 Levels Due to Loss of the Estrogen Responsive Anti-atherogenic Protein, Heat Shock Protein 27? Insights into a Potential New PCSK9 Lowering Therapy

Chunhua Shi - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Comparison of Methods for the Measurement of Cholesterol Efflux Capacity of Plasma HDL with J774 Mouse Macrophages Reveals Superiority of the Radioactive Cholesterol Method over the BODIPY-Cholesterol-2 Method

Renaud Julien - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

filipin

Differential Relationships Between Serum Cholesterol Efflux Capacities Measured From Three Cell Models and Coronary Artery Disease Status in the Montreal Heart Institute Biobank

Low-Kam Cecile - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Predictors of Hospitalization and Effects of Dabigatran and Warfarin on Hospitalization Rates: An Analysis From The Re-ly Trial

Aiman Alak - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Peripheral artery disease

Pradax

Prevention of Diet-induced Metabolic Dysregulation, Inflammation and Atherosclerosis in Ldlr-/- Mice by Treatment with the ACL Inhibitor ETC-1002

Brian G Sutherland - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hypercholesterolemia, Familial, 1

ESP55016

Long-term Efficacy and Safety of Lomitapide for the Treatment of Homozygous Familial Hypercholesterolemia: Results of the Phase 3 Extension Trial

Maurizio Averna - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypercholesterolemia, Familial, 1

Lomitapide

Evaluation of the Protective Effects of Long-term Doxycycline Treatment on Progression of Marfan-associated Aortic Aneurysm by High-resolution Ultrasound Imaging

Ling Lee - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Sinus of valsalva aneurysm

Doxycycline

Reduced Expression of Let-7f Leads to Impaired Ischemia-induced Neovascularization Following Cigarette Smoke Exposure: Role of ALK5/SMAD2/PAI-1 Pathway

Sylvie Dussault - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Cardiac Explant-derived Cells From Aged Donors with Ischemic Cardiomyopathy Demonstrate Impaired Cell Survival and Therapeutic Regeneration

Maryam Kamkar - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Ischemic cardiomyopathy

Superoxide dismutase

Interferon Regulatory Factor 2 Binding Protein 2 Inhibits Macrophage Inflammation and Reduces Susceptibility to Atherosclerosis in Mice and Humans

Hsiao-Huei Chen - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Interferon

The Regenerative Capacity of Explant-derived Cardiac Stem Cells Inversely Correlates with Patient Risk for Future Cardiac Events

Megan Fitzpatrick - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

SDF-1

Rejuvenation of the Bone Marrow-derived Cardiac Resident Sca-1+ Stem Cell Subset Improved Healing of the Aged Heart

Lu Sun - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Impact of Mechanical Unloading on Structural and Non-structural Components of the Extracellular Matrix in Patients with Dilated Cardiomyopathy

Abhijit Takawale - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Dilated cardiomyopathy

Collagenase

Precision Medicine Approach to Resistant Hypertension: Genetic Markers of Resistant Hypertension Through a Genome-wide Association Study (GWAS) in the Secondary Prevention of Subcortical Strokes (SPS3)

Caitrin W McDonough - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

Trandolapril

BRCA2 is a Novel Regulator of Endothelial Cell Function and Apoptosis Following Hyperglycemia

Mohammed Al-Omran - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Vasodilation dysfunction

N/A

Are All Omega-3s Created Equal? Comparison of the Bioavailability and Efficacy of Four Omega-3 Preparations

Carla A Cockerline - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

Discordance Between nonHDLc and Lipoprotein Particle Concentration (apoB and LDLp) in Relation to Future Coronary Events in Women

Akintunde O. Akinkuolie - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Coronary Artery Disease

Hydroxyzine

Women Speak Up About Personalized Heart Health Awareness: A Womens Heart Alliance Research Report

Noel C Bairey Merz - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

Filters

28841 Abstracts